Billiontoone, INC Form 4 insider transactions

Bosch John Roderick Ten, SVP of Laboratory Operations of BillionToOne, Inc., sold 1,417 shares of common stock on August 10, 2026 for $92.86 per share.

David Tsao, Chief Technology Officer and a Director of BillionToOne, Inc., sold 10,000 shares of common stock on August 10, 2026 for $92.86 per share.

Oguzhan Atay, Chairman and CEO and a Director of BillionToOne, Inc., sold 15,539 shares of common stock on August 5, 2026 for $150.03 per share.

Oguzhan Atay, Chairman and CEO and a Director of BillionToOne, Inc., sold 45,000 shares of common stock on August 3, 2026.

Nancy Joann Johnson, See Remarks of BillionToOne, Inc., sold 14,199 shares of common stock on July 16, 2026.

Bosch John Roderick Ten, SVP of Laboratory Operations of BillionToOne, Inc., sold 4,251 shares of common stock on July 13, 2026 for $125.46 per share.

David Tsao, Chief Technology Officer and a Director of BillionToOne, Inc., sold 20,000 shares of common stock on July 13, 2026.

Oguzhan Atay, Chairman and CEO and a Director of BillionToOne, Inc., sold 12,500 shares of common stock on July 9, 2026.

Shan Riku Sakakibara, Chief Product Officer of BillionToOne, Inc., sold 8,000 shares of common stock on July 9, 2026 for $125.00 per share.

BillionToOne CEO Oguzhan Atay reported transactions involving Class A Common Stock, including acquisitions and sales executed under a Rule 10b5-1 trading plan.

Nancy JoAnn Johnson, Senior Vice President of Sales and Commercial Operations at BillionToOne, Inc., reported the sale of 801 shares of Class A Common Stock for $124.9137 per share, executed under a pre-arranged 10b5-1 trading plan.

John Roderick ten Bosch, SVP of Laboratory Operations at BillionToOne, Inc., reported transactions involving Class A Common Stock under a Rule 10b5-1 trading plan.

BillionToOne Chief Product Officer Shan Riku Sakakibara executed a Rule 10b5-1 plan transaction involving Class A Common Stock.

John Roderick ten Bosch, Senior VP of Laboratory Operations at BillionToOne, sold 2,832 shares of Class A Common Stock via a 10b5-1 trading plan.

Chief Technology Officer David Tsao exercised 20,000 stock options and sold a portion of the resulting shares under a Rule 10b5-1 plan.

BillionToOne, Inc. director Thomas S. Bremner was granted 3,017 restricted stock units as part of his compensation.

Director Krishna Kittu Kolluri was granted 3,017 restricted stock units in BillionToOne, Inc. as part of a service-based equity award.

Director Firat Ileri was granted 3,017 restricted stock units in BillionToOne, Inc. as part of standard equity compensation.

Director Anthony Pagano was granted 3,017 restricted stock units as part of his compensation package at BillionToOne, Inc.

Director Akshay Rai was granted 3,017 restricted stock units (RSUs) by BillionToOne, Inc. as part of a service-based equity award.

Director Krishna Kittu Kolluri reported a series of pro-rata, in-kind distributions of BillionToOne, Inc. Class A Common Stock among various investment entities and trusts.

Neotribe Ventures and affiliated entities completed a series of pro-rata, in-kind distributions of BillionToOne, Inc. Class A Common Stock to their respective partners and members.

Chief Product Officer Shan Riku Sakakibara sold 8,000 shares of BillionToOne, Inc. (BLLN) under a pre-arranged 10b5-1 trading plan.

Nancy JoAnn Johnson, SVP of Sales and Commercial Operations at BillionToOne, sold 14,000 shares of Class A Common Stock.

CEO Oguzhan Atay exercised stock options and sold shares of BillionToOne, Inc. under a pre-established Rule 10b5-1 trading plan.

NeoTribe Ventures I, L.P. and affiliated entities have reported significant changes in beneficial ownership of BillionToOne, Inc. Class A Common Stock.

Director Krishna Kittu Kolluri of BillionToOne, Inc. has reported multiple transactions involving Class A Common Stock, primarily through various investment entities.